• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用神经常微分方程处理达巴万星在稀疏临床数据中的群体药代动力学

Leveraging Neural ODEs for Population Pharmacokinetics of Dalbavancin in Sparse Clinical Data.

作者信息

Giacometti Tommaso, Rocchi Ettore, Cojutti Pier Giorgio, Magnani Federico, Remondini Daniel, Pea Federico, Castellani Gastone

机构信息

Department of Physics and Astronomy, Alma Mater Studiorum, University of Bologna, 40126 Bologna, Italy.

INFN Istituto Nazionale di Fisica Nucleare, 40127 Bologna, Italy.

出版信息

Entropy (Basel). 2025 Jun 5;27(6):602. doi: 10.3390/e27060602.

DOI:10.3390/e27060602
PMID:40566189
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12192077/
Abstract

This study investigates the use of Neural Ordinary Differential Equations (NODEs) as an alternative to traditional compartmental models and Nonlinear Mixed-Effects (NLME) models for drug concentration prediction in pharmacokinetics. Unlike standard models that rely on strong assumptions and often struggle with high-dimensional covariate relationships, NODEs offer a data-driven approach, learning differential equations directly from data while integrating covariates. To evaluate their performance, NODEs were applied to a real-world Dalbavancin pharmacokinetic dataset comprising 218 patients and compared against a two-compartment model and an NLME within a cross-validation framework, which ensures an evaluation of robustness. Given the challenge of limited data availability, a data augmentation strategy was employed to pre-train NODEs. Their predictive performance was assessed both with and without covariates, while model explainability was analyzed using Shapley additive explanations (SHAP) values. Results show that, in the absence of covariates, NODEs performed comparably to state-of-the-art NLME models. However, when covariates were incorporated, NODEs demonstrated superior predictive accuracy. SHAP analyses further revealed how NODEs leverage covariates in their predictions. These results establish NODEs as a promising alternative for pharmacokinetic modeling, particularly in capturing complex covariate interactions, even when dealing with sparse and small datasets, thus paving the way for improved drug concentration predictions and personalized treatment strategies in precision medicine.

摘要

本研究探讨了使用神经常微分方程(NODEs)作为传统房室模型和非线性混合效应(NLME)模型的替代方法,用于药代动力学中药物浓度预测。与依赖强假设且常难以处理高维协变量关系的标准模型不同,NODEs提供了一种数据驱动的方法,直接从数据中学习微分方程并整合协变量。为评估其性能,将NODEs应用于包含218名患者的真实世界达巴万星药代动力学数据集,并在交叉验证框架内与二室模型和NLME模型进行比较,以确保对稳健性进行评估。鉴于数据可用性有限的挑战,采用了数据增强策略对NODEs进行预训练。在有和没有协变量的情况下评估了它们的预测性能,同时使用Shapley加法解释(SHAP)值分析了模型的可解释性。结果表明,在没有协变量的情况下,NODEs的表现与最先进的NLME模型相当。然而,当纳入协变量时,NODEs表现出更高的预测准确性。SHAP分析进一步揭示了NODEs在预测中如何利用协变量。这些结果表明NODEs是药代动力学建模的一种有前途的替代方法,特别是在捕捉复杂的协变量相互作用方面,即使在处理稀疏和小数据集时也是如此,从而为精准医学中改进药物浓度预测和个性化治疗策略铺平了道路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a190/12192077/3c8e7e879dcd/entropy-27-00602-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a190/12192077/e229f1f7c86a/entropy-27-00602-g0A1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a190/12192077/79408dfb1e14/entropy-27-00602-g0A2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a190/12192077/53ae844192b0/entropy-27-00602-g0A3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a190/12192077/c916c063ce3f/entropy-27-00602-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a190/12192077/78c2fc3f90a3/entropy-27-00602-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a190/12192077/9ec6e03c35d1/entropy-27-00602-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a190/12192077/df51ddd98171/entropy-27-00602-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a190/12192077/391a170c8291/entropy-27-00602-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a190/12192077/908a554f8d42/entropy-27-00602-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a190/12192077/ee429934890f/entropy-27-00602-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a190/12192077/3c8e7e879dcd/entropy-27-00602-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a190/12192077/e229f1f7c86a/entropy-27-00602-g0A1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a190/12192077/79408dfb1e14/entropy-27-00602-g0A2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a190/12192077/53ae844192b0/entropy-27-00602-g0A3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a190/12192077/c916c063ce3f/entropy-27-00602-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a190/12192077/78c2fc3f90a3/entropy-27-00602-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a190/12192077/9ec6e03c35d1/entropy-27-00602-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a190/12192077/df51ddd98171/entropy-27-00602-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a190/12192077/391a170c8291/entropy-27-00602-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a190/12192077/908a554f8d42/entropy-27-00602-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a190/12192077/ee429934890f/entropy-27-00602-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a190/12192077/3c8e7e879dcd/entropy-27-00602-g008.jpg

相似文献

1
Leveraging Neural ODEs for Population Pharmacokinetics of Dalbavancin in Sparse Clinical Data.利用神经常微分方程处理达巴万星在稀疏临床数据中的群体药代动力学
Entropy (Basel). 2025 Jun 5;27(6):602. doi: 10.3390/e27060602.
2
Does Augmenting Irradiated Autografts With Free Vascularized Fibula Graft in Patients With Bone Loss From a Malignant Tumor Achieve Union, Function, and Complication Rate Comparably to Patients Without Bone Loss and Augmentation When Reconstructing Intercalary Resections in the Lower Extremity?对于因恶性肿瘤导致骨缺损的患者,在重建下肢节段性切除时,采用带血管游离腓骨移植来增强照射后的自体骨移植,其骨愈合、功能及并发症发生率与无骨缺损且未进行增强的患者相比是否相当?
Clin Orthop Relat Res. 2025 Jun 26. doi: 10.1097/CORR.0000000000003599.
3
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.
4
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
5
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
6
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
7
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
8
Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.首次就诊时磁共振灌注成像用于鉴别低级别与高级别胶质瘤
Cochrane Database Syst Rev. 2018 Jan 22;1(1):CD011551. doi: 10.1002/14651858.CD011551.pub2.
9
Stabilizing machine learning for reproducible and explainable results: A novel validation approach to subject-specific insights.稳定机器学习以获得可重复和可解释的结果:一种针对特定个体见解的新型验证方法。
Comput Methods Programs Biomed. 2025 Jun 21;269:108899. doi: 10.1016/j.cmpb.2025.108899.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.

本文引用的文献

1
Low-dimensional neural ordinary differential equations accounting for inter-individual variability implemented in Monolix and NONMEM.在Monolix和NONMEM中实现的考虑个体间变异性的低维神经常微分方程。
CPT Pharmacometrics Syst Pharmacol. 2025 Jan;14(1):5-16. doi: 10.1002/psp4.13265. Epub 2024 Nov 17.
2
Population Pharmacokinetics and Pharmacodynamics of Dalbavancin and C-Reactive Protein in Patients with Staphylococcal Osteoarticular Infections.达巴万星治疗金黄色葡萄球菌骨关节感染患者的群体药代动力学和药效学与 C-反应蛋白的相关性研究。
Clin Pharmacokinet. 2024 Sep;63(9):1271-1282. doi: 10.1007/s40262-024-01410-2. Epub 2024 Aug 22.
3
Implementation and validation of a Bayesian method for accurately forecasting duration of optimal pharmacodynamic target attainment with dalbavancin during long-term use for subacute and chronic staphylococcal infections.
贝叶斯方法在预测达巴万星治疗亚急性和慢性葡萄球菌感染的长期使用中准确预测最佳药效学目标达到时间的应用和验证。
Int J Antimicrob Agents. 2024 Jan;63(1):107038. doi: 10.1016/j.ijantimicag.2023.107038. Epub 2023 Nov 21.
4
Bridging the Worlds of Pharmacometrics and Machine Learning.桥接药物计量学和机器学习的世界。
Clin Pharmacokinet. 2023 Nov;62(11):1551-1565. doi: 10.1007/s40262-023-01310-x. Epub 2023 Oct 6.
5
Population Pharmacokinetic and Pharmacodynamic Analysis of Dalbavancin for Long-Term Treatment of Subacute and/or Chronic Infectious Diseases: The Major Role of Therapeutic Drug Monitoring.达巴万星用于亚急性和/或慢性传染病长期治疗的群体药代动力学和药效学分析:治疗药物监测的主要作用
Antibiotics (Basel). 2022 Jul 24;11(8):996. doi: 10.3390/antibiotics11080996.
6
Neural-ODE for pharmacokinetics modeling and its advantage to alternative machine learning models in predicting new dosing regimens.用于药代动力学建模的神经常微分方程及其在预测新给药方案方面相对于其他机器学习模型的优势。
iScience. 2021 Jun 30;24(7):102804. doi: 10.1016/j.isci.2021.102804. eCollection 2021 Jul 23.
7
Reliability of Supervised Machine Learning Using Synthetic Data in Health Care: Model to Preserve Privacy for Data Sharing.医疗保健中使用合成数据的监督式机器学习的可靠性:用于数据共享时保护隐私的模型
JMIR Med Inform. 2020 Jul 20;8(7):e18910. doi: 10.2196/18910.
8
Efficient Pharmacokinetic Modeling Workflow With the MonolixSuite: A Case Study of Remifentanil.高效药代动力学建模工作流程与 MonolixSuite:瑞芬太尼案例研究。
CPT Pharmacometrics Syst Pharmacol. 2020 Apr;9(4):198-210. doi: 10.1002/psp4.12500. Epub 2020 Mar 31.
9
New lipoglycopeptides: a comparative review of dalbavancin, oritavancin and telavancin.新型糖肽类抗生素:达巴万星、奥他万星和替拉万星的比较综述。
Drugs. 2010 May 7;70(7):859-86. doi: 10.2165/11534440-000000000-00000.
10
Nonlinear mixed effects models for repeated measures data.用于重复测量数据的非线性混合效应模型。
Biometrics. 1990 Sep;46(3):673-87.